Private company gets German stem cell research licence
This article was originally published in Clinica
Executive Summary
Germany's Robert Koch Institute for infectious diseases yesterday granted a licence to import human embryonic stem cells for research to Mainz-based proteomics company, ProteoSys. Although the fourth of its type, the licence is the first to be granted to a company, rather than an individual researcher.